| Issue |
Title |
File |
| Vol 21, No 3 (2019) |
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer |
(Rus)
|
|
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
|
| Vol 22, No 1 (2020) |
The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study |
(Rus)
|
|
Kovalenko E.I., Artamonova E.V., Karabina E.V., Andreiashkina I.I., Prokof’eva E.A., Popova N.O., Gaisina E.A., Evstigneeva I.V., Shaidorov M.V., Zhiliaeva L.A., Ponomarenko D.M., Khasanova A.I., Mukhametshina G.Z., Koziakov A.E., Vorotilina L.V., Povyshev A.I., Simolina E.I., Marfutov V.V., Kozlov D.V., Suslova I.R., Shikina V.E., Karandeeva T.V., Shepel’ A.O., Kramskaia L.V., Oskirko D.A., Frolova O.S.
|
| Vol 15, No 4 (2013) |
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer |
|
|
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V.
|
| Vol 23, No 4 (2021) |
The era of immuno-oncology in onco-urology: what have we achieved?
The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021 |
(Rus)
|
|
Editorial B.
|
| Vol 20, No 3 (2018) |
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer |
(Rus)
|
|
Karabina E.V., Lubchenko L.N., Garunov A.N.
|
| Vol 19, No 3 (2017) |
The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation |
(Rus)
|
|
Kolomeytseva A.A., Yemelyanova G.S., Gorbunova V.A., Orel N.F., Perevodchikova N.I., Bokhyan V.Y., Fedenko A.A.
|
| Vol 26, No 4 (2024) |
The first case of penile metastases of adrenocortical cancer: A clinical case |
(Rus)
|
|
Ognerubov N.A., Antipova T.S.
|
| Vol 26, No 4 (2024) |
The first experience in Russia of applying a tumor differentiation protocol in a patient with progressive, radioiodine-refractory BRAF-positive papillary thyroid cancer. Case report |
(Rus)
|
|
Slashchuk K.Y., Reinberg M.V., Serzhenko S.S., Sheremeta M.S., Nikiforovich P.A.
|
| Vol 20, No 3 (2018) |
The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156 |
(Rus)
|
|
Kuzminov A.E., Gorbunova V.A., Poddubskaya E.V., Bagrova S.G., Baranova M.P., Laktionov K.K.
|
| Vol 20, No 2 (2018) |
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan |
(Rus)
|
|
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
|
| Vol 23, No 1 (2021) |
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia |
(Rus)
|
|
Sokolova T.N., Aleksakhina S.N., Yanus G.A., Sultanbaev A.V., Menshikov K.V., Lysenko A.N., Zukov R.A., Zyuzyukina A.V., Murunova Y.N., Rossokha E.I., Bakharev S.Y., Basova E.A., Kasmynina T.A., Shumskaya I.S., Bakshun Y.I., Musaeva K.S., Khasanova A.I., Dmitriev V.N., Bolieva M.B., Gadzaova C.H., Petrenko O.L., Maksimov D.A., Vladimirov V.I., Goldberg V.E., Popova N.O., Kibisheva M.V., Khamgokov Z.M., Vasilyev A.E., Iyevleva A.G., Imyanitov E.N.
|
| Vol 25, No 3 (2023) |
The frequency of regimens associated with high risk of febrile neutropenia and the incidence of dose-limiting neutropenia among patients receiving cytotoxic therapy for malignancies: the FLAME study results |
(Rus)
|
|
Snegovoy A.V., Kononenko I.B., Sorokina I.V., Berezina A.M., Prosianikova O.N.
|
| Vol 23, No 2 (2021) |
The identification of tumor-infiltrating lymphocytes in patients with stomach cancer |
(Rus)
|
|
Khakimova G.G., Bozhchenko Y.A., Zabotina T.N., Tryakin A.A.
|
| Vol 17, No 2 (2015) |
The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma |
|
|
Motalkina M.S., Kulyova S.A., Alexeev S.M., Zuzgin I.S., Filatova L.V., Zhabina A.S., Zverkova A.A., Ishmatova I.V., Rjazankina A.A., Artemyeva A.S., Semiglazova T.Y.
|
| Vol 23, No 2 (2021) |
The importance of the prevention of treatment induced neutropenia in patients with malignant neoplasms of the head and neck |
(Rus)
|
|
Board E.
|
| Vol 17, No 1 (2015) |
The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council |
|
|
Andrianova V.S., Beliaeva A.V., Bolotina L.V., Vazhenina A.A., Varlamova S.E., Vladimirov V.I., Vladimirova L.Y., Voznyi E.K., Demidov S.M., Zhukov N.V., Zhukova L.G., Imianitov E.N., Kovalenko E.I., Kogoniia L.M., Konstantinova M.M., Lan S.A., Lichinitser M.R., Manziuk L.V., Manikhas A.G., Mukhametshina G.Z., Semiglazov V.F., Semiglazova T.I., Seregina G.V., Stroiakovskii D.L., Ter-Ovanesov M.D., Chichkanova A.S.
|
| Vol 21, No 3 (2019) |
The issues of treatment of primary refractory and relapse patients with diffuse large B-cell lymphoma in the Russian Federation. What awaits us in the future? |
|
|
- -.
|
| Vol 15, No 4 (2013) |
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature) |
|
|
Semiglazov V.F., Semiglazov V.V., Paltuev P.M., Nikolaev K.S., Dashyan G.A.
|
| Vol 24, No 3 (2022) |
The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis |
(Rus)
|
|
Nasretdinov A.F., Menshikov K.V., Sultanbaev A.V., Musin S.I., Sultanbaeva N.I., Men'shikova I.A.
|
| Vol 23, No 3 (2021) |
The modified biopsy technique conducting ultrasound bronchoscopy with endosonographic-guided position of the endoscopic instrument in the area of the pathological focus. The results of the first phase of the clinical trial |
(Rus)
|
|
Pushkarev E.A., Vazhenin A.V., Kulaev K.I., Iusupov I.M., Zuikov K.S., Popova I.A.
|
| Vol 26, No 4 (2024) |
The molecular basis of thyroid status formation and its role in the initiation and promotion of gastric and colorectal cancer: A review |
(Rus)
|
|
Stanoevich I.V., Ioutsi V.A., Lysovolenko N.L., Alekseev I.E., Kondrashkina A.D., Polyansky M.B., Pis'mennaia E.V.
|
| Vol 24, No 4 (2022) |
The NETosis phenomena as a functional features of peripheral blood neutrophils and its role in the pathogenesis of infections and oncological diseases: A review |
(Rus)
|
|
Glukhareva A.E., Afonin G.V., Melnikova A.A., Grivtsova L.Y., Kolobaev I.V., Ivanov S.A., Kaprin A.D.
|
| Vol 18, No 1 (2016) |
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options |
(Rus)
|
|
Artamonova E.V., Manzyuk L.V.
|
| Vol 23, No 3 (2021) |
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous? |
(Rus)
|
|
Sarzhevskiy V.O., Melnichenko V.I., Panshina I.V., Mochkin N.E., Bogatyrov V.S., Borshevetskaya M.M., Smirnova E.G., Bannikova A.E., Samoylova A.A., Mamedova A.A., Rukavitsin A.A., Vasilev S.S., Bronov O.I.
|
| Vol 25, No 4 (2023) |
The place and role of oral microflora in the pathogenesis of oral mucositis in malignant neoplasms (literature review) |
(Rus)
|
|
Zavyalov A.A., Tyryshkin A.I., Olesova V.N., Pashchenko N.A., Gurkova M.M.
|
| Vol 25, No 1 (2023) |
The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases |
(Rus)
|
|
Polyanskaya E.M., Fedyanin M.I.
|
| Vol 20, No 2 (2018) |
The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results) |
(Rus)
|
|
Stepanova A.M., Merzlyakova A.M., Khulamhanova M.M., Trofimova O.P.
|
| Vol 21, No 2 (2019) |
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience |
(Rus)
|
|
Kolyadina I.V., Bulavina I.S., Petkau V.V., Strakhova N.V., Gorbunova V.A., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Gan'shina I.P., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Khokhlova S.V., Filonenko D.V., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Vladimirova L.I., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Orlov A.E., Kostalanova I.V., Levchenko N.V., Osipov M.A., Karandeeva T.V., Evstigneeva I.V., Chernov I.S., Kolokolov D.D., Povyshev A.I., Shatokhina A.S., Cherniakova E.M., Shkodenko O.N., Kuz'mina E.S.
|
| Vol 21, No 1 (2019) |
The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review) |
(Rus)
|
|
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
|
| Vol 19, No 3 (2017) |
The predictive role of interim pet-ct in the treatment of hodgkin's lymphoma in children |
(Rus)
|
|
Kulichkina N.S., Belyaeva E.S., Popa A.V., Valiev T.T., Odzharova A.A., Mentkevich G.L.
|
| Vol 21, No 3 (2019) |
The predictive value of digital mammography, breast ultrasound and their combination in the diagnosis of early breast cancer |
(Rus)
|
|
Alieva G.S., Korzhenkova G.T., Kolyadina I.V.
|
| Vol 26, No 4 (2024) |
The reasons for prescribing antitumor drugs beyond the registered indications in real clinical practice: A retrospective study |
(Rus)
|
|
Karabina E.V., Sakaeva D.D., Lipatov О.N.
|
| Vol 18, No 5 (2016) |
The regional register of multiple myeloma: significance in the era of new drugs |
|
|
Kaplanov K.D., Shirokova M.N.
|
| Vol 23, No 3 (2021) |
The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer |
(Rus)
|
|
Tabakov D.V., Zabotina T.N., Chanturia N.V., Zakharova E.N., Vorotnikov I.K., Selchuk V.Y., Sokolovskiy V.V., Petrovsky A.V.
|
| Vol 16, No 2 (2014) |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013 |
|
|
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A., Koroleva N.I.
|
| Vol 17, No 3 (2015) |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2014 |
|
|
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
|
| Vol 18, No 3 (2016) |
The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015 |
(Rus)
|
|
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
|
| Vol 18, No 3 (2016) |
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia |
(Rus)
|
|
Bolotina L.V., Manziuk L.V., Gorbunova V.A., Kovalenko E.I., Mukhametshina G.Z., Khasanova A.I., Vladimirova L.Y., Mitashok I.S., Prokofyeva E.P., Evstigneeva I.V., Andreyashkina I.I., Abramova N.A., Popova I.L., Karabina E.V., Teterich A.A., Gaysina E.A., Chubenko V.A., Limareva S.V., Tikhanovskaya N.M., Storozhakova A.E., Samaneva N.Y., Svetitskaya Y.V., Snezhko T.A., Kalabanova E.A.
|
| Vol 19, No 1 (2017) |
The results of the treatment of patients with advanced hepatocellular carcinoma in Sverdlovsk region |
(Rus)
|
|
Petkau V.V., Tarkhanov A.A., Kiselev E.A.
|
| Vol 17, No 2 (2015) |
The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients |
|
|
Frank G.A., Ilatovskaia M.E., Andreeva I.I., Zavalishina L.E.
|
| Vol 26, No 4 (2024) |
The role of ESR1 gene mutation in therapy selection for HR+/HER2- metastatic breast cancer: A review |
(Rus)
|
|
Paichadze A.A., Chashnikova E.P., Golubeva S.A.
|
| Vol 21, No 4 (2019) |
The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma |
(Rus)
|
|
Kit O.I., Vladimirova L.I., Storozhakova A.E., Snezhko T.A., Kalabanova E.A., Samaneva N.I., Svetitskaia I.V., Kabanov S.N.
|
| Vol 15, No 4 (2013) |
The role of angiogenesis blockers in the treatment of metastatic ovarian cancer |
|
|
Oganian M.R., Kazantseva M.V., Davidenko I.S., Porhanova N.V.
|
| Vol 19, No 1 (2017) |
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer |
(Rus)
|
|
Khokhlova S.V.
|
| Vol 20, No 3 (2018) |
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer |
(Rus)
|
|
Kolyadina I.V., Poddubnaya I.V.
|
| Vol 16, No 1 (2014) |
The role of cytokines in the chemotherapy of malignant tumors:the practice of cytokines Refnot® and Ingaron® administration in advanced cancer with multiple metastases |
|
|
Bryuzgin V.V., Platinskij L.N.
|
| Vol 20, No 1 (2018) |
The role of cytoreduction surgery in advanced ovarian cancer (review) |
(Rus)
|
|
Tandelov R.K., Sel'chuk V.Y., Morkhov K.Y., Nechushkina V.M., Kuznetsov V.V.
|
| Vol 26, No 1 (2024) |
The role of direct oral anticoagulants in cancer-associated thrombosis. Review of clinical guidelines and real practice |
(Rus)
|
|
Tereshin O.S.
|
| Vol 25, No 1 (2023) |
The role of minimal residual disease in therapy of pediatric acute lymphoblastic leukemia: a prospective cohort study |
(Rus)
|
|
Korkina Y.S., Valiev T.T.
|
| Vol 24, No 2 (2022) |
The role of molecular genetic factors in the development of cholangiocellular cancer: A review |
(Rus)
|
|
Chulkova S.V., Loginov V.I., Podluzhny D.V., Egorova A.V., Semichev D.G., Gladilina I.A., Kudashkin N.E.
|
| Vol 18, No 3 (2016) |
The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer |
(Rus)
|
|
Frolova M.A.
|
| Vol 25, No 2 (2023) |
The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study |
(Rus)
|
|
Khatkov I.E., Semenov N.N., Izrailov R.E., Efanov M.G., Dalgatov K.D., Zhukova L.G.
|
| Vol 23, No 1 (2021) |
The role of positron emission tomography in different types of malignant lymphomas: the results of 2020 |
(Rus)
|
|
Sarzhevskiy V.O., Mukhortova O.V.
|
| Vol 22, No 4 (2020) |
The role of radiation therapy in the treatment of patients with pleural mesothelioma |
(Rus)
|
|
Borisova T.N., Tkachev S.I., Ivanov S.M., Alieva S.B., Trofimova O.P., Glebovskaya V.V., Breder V.V., Laktionov K.K., Marinov D.T., Abdullaev A.G.
|
| Vol 18, No 2 (2016) |
The role of regorafenib in the treatment of metastatic colorectal cancer |
(Rus)
|
|
Tryakin A.A.
|
| Vol 21, No 4 (2019) |
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution |
(Rus)
|
|
Poddubnaya I.V., Bialik T.E., Glonina N.N., Kalashnikova O.B., Kaplanov K.D., Lapin V.A., Medvedeva N.V., Mikhailova N.B., Moiseeva T.N., Nikitin E.A., Pospelova T.I., Stadnik E.A.
|
| Vol 16, No 1 (2014) |
The role of tamoxifen in the therapy of metastatic ovarian cancer |
|
|
Davidenko I.S., Kazantseva M.V., Porhanova N.V., Ohanyan M.R.
|
| Vol 17, No 1 (2015) |
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma |
|
|
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
|
| Vol 16, No 1 (2014) |
The role of topotecan in prolongation of platinum-free interval in patients with recurrent ovarian cancer |
|
|
Moskovskaya E.U., Novikova E.G., Korneeva I.A.
|
| Vol 23, No 2 (2021) |
The Russian Expert Council on the application of new highly selective inhibitor of Bruton’s tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma. Event review |
(Rus)
|
|
Kaplanov K.D.
|
| Vol 24, No 3 (2022) |
The surgical treatment of locally advanced angiosarcoma of the anterior mediastinum. A clinical case |
(Rus)
|
|
Novikov D.V., Chekini A.K., Avturkhanov T.M., Mkrtumyan R.A.
|
| Vol 23, No 4 (2021) |
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem
The results of the project with the discussion concerning the possibility of optimization approaches for the therapy |
(Rus)
|
|
Editorial B.
|
| Vol 24, No 2 (2022) |
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review |
(Rus)
|
|
Rykov I.V., Chubenko V.A.
|
| Vol 19, No 2 (2017) |
The treatment of patients with advanced lung cancer associated with EGFR mutation |
(Rus)
|
|
Bolotina L.V.
|
| Vol 17, No 3 (2015) |
The treatment of patients with metastatic brain tumors Draft clinical guidelines |
|
|
Golanov A.V., Bekiashev A.K., Dolgushin M.B., Kobiakov G.L., Naskhletashvili D.R., Smolin A.V., Nazarenko A.V., Medvedev S.V., Ilialov S.R., Vetlova E.R., Banov S.M.
|
| Vol 23, No 2 (2021) |
The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report |
(Rus)
|
|
Ognerubov N.A., Antipova T.S.
|
| Vol 17, No 1 (2015) |
The use of combined plastic interventions in the reconstruction of post-operative soft tissue defects of the chest wall in the surgical treatment of locally advanced breast cancer |
|
|
Vashenko L.N., Daschkova I.R., Bakulina S.M., Andreyko E.A.
|
| Vol 23, No 2 (2021) |
The use of erythropoietins in oncology |
(Rus)
|
|
Ziganshina L.E., Poddubnaia I.V., Sychev D.A.
|
| Vol 25, No 4 (2023) |
The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast |
(Rus)
|
|
Shabaev R.M., Khodyrev S.A., Kolyadina I.V., Blagovestnov D.A., Starokon P.M.
|
| Vol 20, No 1 (2018) |
The use of low molecular weight heparin Enixum® in the prevention and treatment of thrombosis in oncology |
(Rus)
|
|
Somonova O.V., Elizarova A.L., Matveeva I.I.
|
| Vol 18, No 4 (2016) |
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice |
(Rus)
|
|
Khokhlova S.V.
|
| Vol 21, No 2 (2019) |
The use of regorafenib in colorectal cancer |
(Rus)
|
|
Sekacheva M.I., Bagmet N.N., Guryanova A.A., Rashi D.A.
|
| Vol 22, No 4 (2020) |
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review |
(Rus)
|
|
Poddubnaya I.V., Gligorov J., Zhukova L.G., Kovalenko E.I., Frolova M.A.
|
| Vol 15, No 4 (2013) |
The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC |
|
|
Orlov S.V.
|
| Vol 18, No 4 (2016) |
Therapy for patients with non-small cell lung cancer in the Russian Federation: EPICLIN-Lung study |
|
|
Tyulyandin S.A., Imyanitov E.N., Moiseyenko V.M., Ponomarenko D.M., Gurina L.I., Koroleva I.A., Karaseva V.V.
|
| Vol 25, No 1 (2023) |
Therapy of chronic pain in cancer patients: Tafalgin use experience. Case report |
(Rus)
|
|
Ognerubov N.A.
|
| Vol 22, No 2 (2020) |
Therapy of Hodgkin lymphoma in Russia during the COVID-19 pandemic |
(Rus)
|
|
Poddubnaya I.V., Baryakh E.A., Vorobyev V.I., Demina E.A., Zhukov N.V., Kaplanov K.D., Konstantinova T.S., Motorin D.V., Ptushkin V.V., Sarzhevsky V.O., Tumyan G.S.
|
| Vol 24, No 1 (2022) |
Therapy of lymphoproliferative diseases in the era of COVID-19: challenges and solutions |
(Rus)
|
|
Poddubnaya I.V.
|
| Vol 18, No 3 (2016) |
Therapy results of advanced-stag Hodgkin lymphoma in Khabarovsk district |
(Rus)
|
|
Kanin V.S., Kanin E.S., Dolgaleva M.I.
|
| Vol 26, No 3 (2024) |
Tolerability of perioperative chemotherapy for gastric cancer in real clinical practice |
(Rus)
|
|
Fedorinov D.S., Lyadova M.A., Lyadov V.K.
|
| Vol 2, No 4 (2000) |
Tomudeks - novyy effektivnyy protivoopukholevyy preparat |
|
|
Lichinitser M.R.
|
| Vol 4, No 4 (2002) |
Topotekan v kachestve II linii khimioterapii raka yaichnikov |
|
|
Gorbunova V.A.
|
| Vol 4, No 1 (2002) |
Topotekan v lechenii raka legkogo: novye vozmozhnosti terapii |
|
|
Bychkov M.B.
|
| Vol 26, No 1 (2024) |
Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study |
(Rus)
|
|
Volkova M.I., Kalpinskiy A.S., Goncharova O.A., Menshikov K.V., Karabina E.V., Dergunov A.S., Polshina N.I., Alexandrova E.N., Lebedinets A.A., Panov A.К., Sultanbaev A.V., Usynin E.A., Volkonskiy M.V., Mikhalyuk V.V., Zukov R.A., Anzhiganova Y.V., Gusniev M.A., Igumnova E.N., Kuzmicheva S.V., Pokataev I.A., Olshanskaya A.S., Pervakova N.I., Parsadanova E.L., Sannikova T.A., Bystrov A.A., Dubovichenko D.M., Miliausha M.R., Chubenko V.A., Shkret K.A., Gorshenina M.N., Davlatova M.К., Kosareva A.E., Lutoshkina O.A., Maslova O.A., Makhnutina M.V., Mishina A.V., Murzalina M.Z., Podyacheva O.A., Kalinin S.A., Mailyan O.A., Safarova A.R., Semenova K.O., Strokova M.A., Urashkina E.Y., Shmygina O.S.
|
| Vol 15, No 2 (2013) |
Toxicity of trabectedin-based combinations in the treatment of different malignant tumors |
|
|
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Orel N.F., Gorbounova V.A., Poddubnaya I.V., Lyubimova N.V.
|
| Vol 12, No 3 (2010) |
Trabektedin v lekarstvennom lecheniisarkom myagkikh tkaney |
|
|
Gorbunova V.A., Aliev M.D., Fedenko A.A., Bokhyan B.Y., Istomin I.A.
|
| Vol 18, No 3 (2016) |
Tracheal and bronchial plastic resection in patients with lung cancer |
(Rus)
|
|
Khvastunov R.A., Usachev A.A.
|
| Vol 3, No 1 (2001) |
Translokatsiya t(8;21)(q22;q22) pri ostrom mieloblastnom leykoze u detey |
|
|
Baturina Y.A., Popa A.V., Fleyshman E.V., Sokova O.I., Kirichenko O.P., Konstantinova L.N., Kulagina O.E., Mayakova S.A.
|
| Vol 24, No 2 (2022) |
Transthoracic biopsy under the control of computed tomography as a method of differential diagnosis of nodular neoplasms of the lung in outpatient settings: Retrospective cohort study |
(Rus)
|
|
Perepelevskiy A.N., Stanojevic U.S., Lazarenko V.A., Grebenkin E.N., Sumina O.E.
|
| Vol 21, No 1 (2019) |
Transthoracic biopsy under the control of computer tomography as a method for safe and effective morphological verification of the tumors of the chest cavity |
(Rus)
|
|
Perepelevskiy A.N., Kiselev I.L., Nikulin A.I., Perepelevskaya Y.E., Frolova E.Y.
|
| Vol 23, No 1 (2021) |
Treatment of advanced small cell lung cancer. Clinical case and literature review |
(Rus)
|
|
Menshikov K.V., Sultanbaev A.V., Musin S.I., Menshikova I.A., Nasretdinov A.F., Sultanbaeva N.I.
|
| Vol 21, No 1 (2019) |
Treatment of cancer-related thrombosis: from recommendations to real clinical practice |
(Rus)
|
|
Somonova O.V., Elizarova A.L., Blindar V.N., Dobrovolskaya M.B., Nesterova Y.A., Borisenko N.N., Kornyushenko U.A., Davidova T.V.
|
| Vol 22, No 1 (2020) |
Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial |
(Rus)
|
|
Levashov A.S., Zagidullina S.R., Stroganova A.M., Khochenkov D.A., Ryzhova M.V., Gorelyshev S.K., Kadirov S.U., Babelyan S.S., Grigorenko V.A., Sidel’nikov D.A., Subbotina N.N., Daylidite V.V., Mentkevich G.L.
|
| Vol 23, No 1 (2021) |
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review |
(Rus)
|
|
Menshikov K.V., Sultanbaev A.V., Akhmetgareeva K.T., Lipatov D.O.
|
| Vol 17, No 2 (2015) |
Treatment of severe nosocomial infections: doripenem - a new carbapenems antibiotic |
|
|
Petukhova I.N., Dmitrieva N.V.
|
| Vol 27, No 1 (2025) |
Treatment outcomes in patients with growing teratoma syndrome: A review |
(Rus)
|
|
Nechushkina I.V., Nechushkina V.M., Boychenko E.I., Susuleva N.A.
|
| Vol 14, No 2 (2012) |
Tretichnyy pokazatel' Glisona kak faktor prognoza retsidiva raka predstatel'noy zhelezy |
|
|
Ognerubova I.N., Poddubnaya I.V., Matveev V.B., Khvan O.T.
|
| Vol 3, No 2 (2001) |
Tri rezhima khimioterapii disseminirovannogo kolorektal'nogo raka |
|
|
Narimanov M.N., Bazin I.S., Mamedov F.F., Efimov O.N., Tryakin A.A., Zharkov S.A., Tyulyandin S.A., Garin A.M.
|
| Vol 3, No 4 (2001) |
Tri rezhima khimioterapii disseminirovannogo kolorektal'nogo raka |
|
|
Narimanov M.N., Bazin I.S., Mamedov F.F., Efimov O.N., Tryakin A.A., Zharkov S.A., Tyulyandin S.A., Garin A.M.
|
| Vol 24, No 3 (2022) |
Triple-negative breast cancer: new options for systemic targeted therapy. A review |
(Rus)
|
|
Andreev D.A., Zavyalov A.A.
|
| Vol 4, No 4 (2002) |
Trofoblasticheskaya bolezn': novyy vzglyad na lechenie i monitoring |
|
|
Meshcheryakova L.A., Kozachenko V.P.
|
| Vol 14, No 4 (2012) |
Tselesoobraznost' prodolzheniya terapii bevatsizumabom posle progressirovaniya u bol'nykh metastaticheskim kolorektal'nym rakom |
|
|
Dobrova N.V., Gutorov S.L., Chernoglazova E.V.
|
| Vol 10, No 4 (2008) |
Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka |
|
|
Sekacheva M.I., Skipenko O.G.
|
| Vol 10, No 3 (2008) |
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy |
|
|
Besova N.S., Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
|
| Vol 8, No 1 (2006) |
Tsitologicheskaya diagnostika zlokachestvennykh limfom |
|
|
Kondrat'eva T.T.
|
| Vol 16, No 4 (2014) |
Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I? |
|
|
Kolyadina I.V., Poddubnaya I.V., Trofimova O.P., Frank G.A., Karseladze A.I., Komov D.V.
|
| Vol 2, No 2 (2000) |
Ul'trazvukovaya diagnostika v onkologii. Novye napravleniya i perspektivy razvitiya |
|
|
Sholokhov V.N.
|
| Vol 9, No 1 (2007) |
Ul'trazvukovye kriterii effektivnosti lecheniya raka yaichnikov |
|
|
Sinitsina M.E., Chekalova M.A., Gorbunova V.A., Kedrova A.G., Mazyrko M.A.
|
| Vol 21, No 2 (2019) |
Unresectable hepatocellular carcinoma: new opportunities and prospects for therapy |
(Rus)
|
|
Abdurakhmanov D.T., Breder V.V., Bolotina L.V., Kosyrev V.I., Medvedeva B.M., Petkau V.V.
|
| Vol 25, No 1 (2023) |
Updates in urologic oncology guidelines: prostate cancer: A review |
(Rus)
|
|
Volkova M.I., Alekseev B.Y., Nosov D.A., Nyushko K.M.
|
| Vol 25, No 2 (2023) |
Updates in urologic oncology guidelines: renal cell carcinoma. A review |
(Rus)
|
|
Volkova M.I., Nosov D.A., Alekseev B.Y.
|
| Vol 25, No 2 (2023) |
Updates in urologic oncology guidelines: urothelial carcinoma. A review |
(Rus)
|
|
Volkova M.I., Alekseev B.Y., Gladkov O.A.
|
| Vol 26, No 4 (2024) |
Use of granulocyte colony-stimulating factors in patients with HIV-associated lymphoproliferative diseases receiving cytotoxic therapy: Experience of a research center |
(Rus)
|
|
Kremneva N.V., Dudina G.A., Tagieva E.U., Tokmakova A.A., Nemykin V.N.
|
| Vol 22, No 3 (2020) |
Use of nivolumab for colon cancer with Lynch syndrome |
(Rus)
|
|
Khakimov G.A., Tryakin A.A., Khakimova G.G.
|
| Vol 25, No 3 (2023) |
Use of psychological interventions in women diagnosed and under treatment for non-metastatic breast cancer [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] |
(Rus)
|
|
Mustafina F.U.
|
| Vol 19, No 2 (2017) |
Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer |
(Rus)
|
|
Kit O.I., Vladimirova L.Y., Abramova N.A., Storozhakova A.E., Popova I.L., Tikhanovskaya N.M., Lyaynova A.A., Ryadinskaya L.A.
|
| Vol 14, No 2 (2012) |
V Moskve sostoyalos' obsuzhdenie proekta Rossiyskikh klinicheskikh rekomendatsiy po diagnostike i lecheniyu zlokachestvennykh limfoproliferativnykh zabolevaniy, osnovannykh na printsipakh dokazatel'noy meditsiny i mnenii ekspertov |
|
|
- -.
|
| Vol 14, No 1 (2012) |
V pamyat' o M.M.Kaverznevoy |
|
|
- -.
|
| Vol 12, No 4 (2010) |
V Rossii startoval innovatsionnyy proekt «GistoLogika»Moskva, dekabr' 2010 g. |
|
|
- -.
|
| Vol 14, No 4 (2012) |
V Rossii zaregistrirovan Ksalkori®(krizotinib) kak pervyy i edinstvennyypreparat dlya lecheniya ALK-pozitivnogonemelkokletochnogo raka legkogo |
|
|
- -.
|
| Vol 14, No 3 (2012) |
Variant techeniya kholangiokartsinomy: obzor literatury i sobstvennoe klinicheskoe nablyudenie |
|
|
Maev I.V., Dicheva D.T., Andreev D.N., Penkina T.V., Senina Y.S.
|
| Vol 24, No 1 (2022) |
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary) |
(Rus)
|
|
Staroverova T.A.
|
| Vol 15, No 2 (2013) |
VEGF inhibitors: a new era in the treatment of metastatic ovarian cancer |
|
|
Pignata S.
|
| Vol 11, No 4 (2009) |
Vektibiks (panitumumab) – novoe monoklonal'noe antitelok retseptoram epidermal'nogo faktora rosta pri lechenii metastaticheskogo kolorektal'nogo raka |
|
|
Tryakin A.A., Tyulyandin S.A.
|
| Vol 26, No 1 (2024) |
Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment |
(Rus)
|
|
Fedyanin M., Rumyantsev A.A., Tryakin A.A.
|
| Vol 13, No 3 (2011) |
Venoznye tromboembolicheskieoslozhneniya na fone preparatov,stimuliruyushchikh eritropoez.Diskussiya prodolzhaetsya |
|
|
Roytman E.V.
|
| Vol 3, No 1 (2001) |
Vepezid v kapsulakh: novye vozmozhnosti primeneniya |
|
|
Meshcheryakova N.G.
|
| Vol 5, No 3 (2003) |
Videotarakoskopicheskaya parasternal'naya limfodissektsiya v diagnostike raka molochnoy zhelezy |
|
|
Nechushkin M.I., Bekuzarova N.V., Trigolosov A.V., Uymanov V.A., Petrovskiy A.V., Poddubnaya I.V.
|
| Vol 22, No 2 (2020) |
Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case |
(Rus)
|
|
Gorbunova T.V., Radtsig E.I., Merkulov O.A., Bogomil’skii M.R., Poliakov V.G.
|
| Vol 10, No 2 (2008) |
Vliyanie endokhirurgicheskogo vmeshatel'stva na protivoopukholevuyu rezistentnost' organizma |
|
|
Sletina S.Y., Komarov I.G.
|
| Vol 9, No 4 (2007) |
Vliyanie immunomodulyatora Galavit na immunologicheskiy status bol'nykh nemelkokletochnym rakom legkogo II-III stadii |
|
|
Vel'sher L.Z., Gabuniya Z.R., Grishina T.I., Germanov A.B., Korobkova L.I., Platonov D.A., Argun V.M., Gens G.P.
|
| Vol 20, No 3 (2018) |
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo |
(Rus)
|
|
Novikov D.V., Polotskiy B.E., Bogush T.A., Davidov M.M., Ahmedov B.B., Rotobelskaya L.E.
|
| Vol 8, No 4 (2006) |
Vliyanie rekonstruktivno-plasticheskikh operatsiy na kachestvo zhizni bol'nykh rakom molochnoy zhelezy v otdalennom periode |
|
|
Arslanov K.S., Tkachenko G.A.
|
| Vol 5, No 1 (2003) |
Vliyanie stressoobrazuyushchego faktora - podozrenie i postanovka diagnoza "rak molochnoy zhelezy " - na parametry serdechno dykhatel'nogo sinkhronizma u zhenshchin s razlichnymi tipami nervnoy sistemy |
|
|
Pokrovskiy V.M., Arkad'eva T.V., Selivanova T.I.
|
| Vol 14, No 3 (2012) |
Vmeste k novym dostizheniyam v lechenii limfoproliferativnykh zabolevaniyKlinicheskiy limforum, Irkutsk, 23-24 avgusta 2012 g., i novye plany na 2012- 2013 gg. |
|
|
Poddubnaya I.V.
|
| Vol 13, No 1 (2011) |
Vozmozhnost' ispol'zovaniya ingibitorov tirozinkinazy v lechenii bol'nykh nemelkokletochnymrakom legkogo s mutatsiyami gena retseptora epidermal'nogo faktora rosta (obzor) |
|
|
Orel N.F.
|
| Vol 8, No 1 (2006) |
Vozmozhnosti endoskopicheskoy i differentsial'noy diagnostiki ekstranodal'nykh b-kletochnykh limfom zheludka marginal'noy zony MALT-tipa |
|
|
Malikhova O.A., Poddubnyy B.K., Kuvshinov Y.P., Poddubnaya I.V., Moskalenko O.A., Kondrat'eva T.T., Kokasadze N.V., Sholokhova E.V., Frolova I.P.
|
| Vol 4, No 4 (2002) |
Vozmozhnosti ispol'zovaniya taksotera pri razlichnykh solidnykh opukholyakh |
|
|
Gorbunova V.A., Orel N.F., Borisova T.A., Besova N.S., Marenich A.F., Bychkov M.B., Khokhlova S.V., Naskhletashvili D.R.
|
| Vol 11, No 2 (2009) |
Vozmozhnosti ispol'zovaniya tsetuksimaba dlya lecheniya bol'nykh kolorektal'nym rakom |
|
|
Orlova R.V., Tyukavina N.V.
|
| Vol 12, No 3 (2010) |
Vozmozhnosti khimioterapii rakamolochnoy zhelezy, rezistentnogok antratsiklinam i taksanam |
|
|
Besova N.S., Gorbunova V.A.
|
| Vol 14, No 3 (2012) |
Vozmozhnosti khirurgicheskogo lecheniya mestnorasprostranennogo i retsidivnogo raka rotoglotki |
|
|
Sikorskiy D.V., Podvyaznikov S.O., Chernyavskiy A.A., Volodin A.N.
|
| Vol 15, No 3 (2013) |
Vozmozhnosti lekarstvennoy terapii neoperabel'noy i metastaticheskoy bazal'no-kletochnoy kartsinomy kozhi |
|
|
Levchenko E.V.
|
| Vol 7, No 3 (2005) |
Vozmozhnosti lekarstvennoy terapii raka sheyki matki |
|
|
Kharitonova T.V.
|
| Vol 9, No 2 (2007) |
Vozmozhnosti plasticheskoy khirurgii pri operatsiyakh po povodu opukholey golovy i shei |
|
|
Shinkarev S.A., Podol'skiy V.N., Kozlovskaya E.V., Korenev A.A.
|
| Vol 9, No 1 (2007) |
Vozmozhnosti primeneniya Fragmina pri provedenii gemodializa onkologicheskim bol'nym |
|
|
Gromova E.G., Madzhuga A.V., Somonova O.V., Kuznetsova L.S., Elizarova A.L.
|
| Vol 3, No 4 (2001) |
Vozmozhnosti primeneniya kleksana v onkologii |
|
|
Poddubnaya I.V., Podregul'skiy K.E.
|
| Vol 4, No 4 (2002) |
Vozmozhnosti primeneniya kselody (kapetsitabina) v lechenii disseminirovannogo raka molochnoy zhelezy, rezistentnogo k antratsiklinovym antibiotikam i taksoteru (dotsetakselu) |
|
|
Gershanovich M.L., Semiglazova T.Y.
|
| Vol 4, No 1 (2002) |
Vozmozhnosti primeneniya proizvodnykh nitrozometilmocheviny i vepezida v khimioterapii mnozhestvennoy mielomy i zlokachestvennykh limfom |
|
|
Bessmel'tsev S.S., Abdulkadyrov K.M.
|
| Vol 2, No 1 (2000) |
Vozmozhnosti primeneniya sandostatina u onkologicheskikh bol'nykh |
|
|
Orel N.F., Lopatkina T.N.
|
| Vol 12, No 2 (2010) |
Vozmozhnosti primeneniya sorafenibav neoad\"yuvantnom rezhimepri pochechno-kletochnom rake |
|
|
Poddubnaya I.V., Ognerubova I.N.
|
| 1201 - 1350 of 1398 Items |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
